3Boonen S,Mohan S,Dequeker J,et al.Down regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system(IGF-Ⅰ,IGF-Ⅱ,IGFBp-3 and IGFBp-5) in agerelated (type Ⅱ) femoral neck osteoporosis.J of Bone and Miner Res,1999,14:2150-2158.
4Polak-Jonkisz D,Zwolinska D,Bednorz R,et al.Usefulness of osteocalcin and CrossLaps as markers of bone turnover in children with chronic renal failure.Pol Merkur Lekarski,2002,12(70):257-60.
5Santos F,Carbajo-Perez E,Rodriguez J,et al.Alterations of the growth plate in chronic renal failure.Pediatr Nephrol,2005,20 (3):330-4.
6Kotzmann H,Riedl M,Pietschmann P,et al.Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.J Nephrol,2004,17(1):87-94.
7Doumouchtsis KK,Kostakis AI,Doumouchtsis SK,et al.The effect of sexual hormone abnormalities on proximal femur bone mineral density in hemodialysis patients and the possible role of RANKL.Hemodial Int,2008,12(1):100-107.
8Messa P,Mioni G,Turrin D,et al.The calcitonin-calcium relation curve and calcitonin secretory parameters in renal patients with variable degrees of renal function.Nephrol Dial Transplant,1995,10(12):2259-2265.
